Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Rash erythematous, Vaccination site pruritus
Clinical narrative: it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my; it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my; a little bit of itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (a little bit of itching), RASH ERYTHEMATOUS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) and INJECTION SITE MASS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (a little bit of itching). On 27-Jan-2021, the patient experienced RASH ERYTHEMATOUS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) and INJECTION SITE MASS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my). On 29-Jan-2021, VACCINATION SITE PRURITUS (a little bit of itching) had resolved. At the time of the report, RASH ERYTHEMATOUS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) and INJECTION SITE MASS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (a little bit of itching), RASH ERYTHEMATOUS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) and INJECTION SITE MASS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (a little bit of itching). On 27-Jan-2021, the patient experienced RASH ERYTHEMATOUS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) and INJECTION SITE MASS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my). On 29-Jan-2021, VACCINATION SITE PRURITUS (a little bit of itching) had resolved. At the time of the report, RASH ERYTHEMATOUS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) and INJECTION SITE MASS (it was red, rash, bumpy but not much, still a little bit itchy, about 6-8 inches across around my) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.